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ABSTRACT Poly(dG-dC)-poly(dG-dC) and Micrococcus Iy8O-
deikticus DNA were modified by exposure to reductively acti-
vated mitomycin C, an antitumor antibiotic. The resulting cova-
lent drug-polynucleotide complexes displayed varying degrees of
CD inversions, which are strikingly similar to the inverted spec-
trum observed with Z-DNA. The following criteria have been used
to establish, however, that the inverted CD pattern seen in mi-
tomycin C-polynucleotide complexes does not reflect a Z-DNA
conformation. (i) The ethanol-induced transition of poly(dG-
dC)'poly(dG-dC) from B to Z conformation is not facilitated but
rather is inhibited by mitomycin C modification. This may be due
to the presence of crosslinks. (ii) Radioimmunoassay indicated no
competition for Z-DNA-specific antibody by any of the mitomycin
C-modified polynucleotides. (U1) 31P NMR of the complexes yielded
a single relatively narrow resonance, which is inconsistent with
the dinucleotide repeat characteristic of Z-DNA. Alternative ex-
planations for the inverted CD pattern include a drug-induced
left-handed but non-Z conformational change or the superposition
of an induced CD onto the CD of B-DNA due to drug-base elec-
tronic interactions. These results illustrate the need for caution in
interpreting CD changes alone as an indication of Z-DNA con-
formation.
Mitomycin C (MC; structure I), an antibiotic and antitumor agent,
binds covalently to DNA when activated by reductive metab-
olism in vivo or in vitro (1). Crosslinks between the comple-
mentary strands are also formed in this interaction as relatively
rare events compared to the monofunctional binding (1).
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Some years ago, we noted a remarkable property of MC-DNA
complexes: Their CD spectra showed a characteristic progres-
sive change with increasing levels of MC binding (2). The same
type of change, except much greater in magnitude, was seen
with MC-poly(dG-dC).poly(dG-dC) but not with MC-
poly(dG)-poly(dC) or MC-RNA complexes, all compared at the
same level of substitution by the drug (2). We noted that the
CD changes and their specificity are strikingly similar to those
occurring when poly(dG-dC).poly(dG-dC) itself is submitted to
high salt concentration (4 M NaCl or 1 M MgCl2) as described
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by Pohl and Jovin some years earlier (3) (Fig. 1). These latter
conditions induced a cooperative transition of the regular B form
of poly(dG-dC)poly(dG-dC) to a new conformation, unique to
the alternating dG-dC sequence, the nature of which was un-
known at the time except for its characteristic "inverted" CD
(Fig. 1) and slightly altered UV spectrum. To account for the
striking similarities between the MC-induced and salt-induced
CD changes, we suggested (2), as one of several alternative ex-
planations, that covalent binding of the positively charged MC
ligand (structure II) to guanine residues of alternating dC-dG
sequences induces and stabilizes the same new conformation as
that induced by high salt concentration, whereas binding to
guanine in other sequence environments does not produce such
a change.
In the light of the discovery of crystalline Z-DNA, a left-
handed double helix of unique structure (4), it soon became
firmly evident that the salt-induced form of poly(dG-dC)-
poly(dG-dC) in solution is alsoZ-DNA (5-7). Consequently, based
on the above similarities, MC emerged as a strong candidate for
a drug that is capable of inducing Z-DNA conformation upon
binding to appropriate, alternating dG-dC sequences (4, 8).
In view of the extraordinary current interest in both struc-
tural aspects and biological significance of Z-DNA (see, e.g.,
ref. 9), it seemed timely to seek further evidence beyond the
CD that would establish firmly whether this was indeed the
case. MC is particularly interesting because the CD effect is
seen not only with poly(dG-dC)-poly(dG-dC) but also with nat-
urally occurring DNAs (2). As our objective, we probed both
types of systems, specifically, MC-poly(dG-dC)poly(dG-dC)
and MC-Micrococcus lysodeikticus DNA complexes for Z-DNA
properties by three different powerful methods: (i) comparison
of the ethanol-induced B -- Z transition (10) of the complex
with that of poly(dG-dC)poly(dG-dC), (ii) 31P NMR, and (iii)
radioimmunoassay (RIA).
MATERIALS AND METHODS
Materials used and their sources are as follows: mitomycin C,
Bristol Laboratories (Syracuse, NY); oligo(dA)1o and oligo-
(dA)12 18, Collaborative Research (Waltham, MA); bacterial al-
kaline phosphatase and snake venom diesterase, Worthington-
Millipore; and DNase I (pancreatic; type I), Sigma.
M. lysodeikticus DNA (Miles) was sonicated by using a Bran-
son W140 sonicator and following a published protocol (11) and
then was deproteinized by the Marmur procedure.
Poly(dG-dC)poly(dG-dC) (P-L Biochemicals) was used with-
out further purification. For the 31P NMR experiments, it was
Abbreviations: MC, mitomycin C; CD, circular dichroism; RIA, ra-
dioimmunoassay.
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B FIG. 1. CD spectra. (A) ,
2 Nucleose-resistont "core" poly(dG-dC) poly(dG-dC) in 0.017from MC complex M sodium phosphate, pH 7.5/0.1
\ 7\\./ MC-DNA complex mM EDTA; ---, same polymer inl \,;ethe same buffer with 4 M NaCl;
i;// \'I\_<Control DNA ---, MC-poly(dG-dC)'poly(dG-dC)
cs : / : X \complex (binding ratio, 0.25) in
o-- A d . /1/ 'A 017Msodium phosphate, pH 7.5/
. A,~~~~~~~~~.1 mM EDTA (replotted from fig-
ure 8 in ref. 2). (B) ---, M. lyso-
deikticus DNA-MC complex (bind-
ing ratio, 0.15); - --, nuclease-resis-
2 tant MC-oligonucleotide core from
the same complex (binding ratio,
l 0.25); , control DNA. All were
220 260 300 340 in 0.012 M Tris, pH 7.4/1 mM
nm EDTA.
sonicated exactly as described (12). Unsonicated polymer was
used in all other experiments.
MC-poly(dG-dC)poly(dG-dC) complexes with various bind-
ing ratios were prepared as published (2). MC-M. lysodeikticus
DNA complexes were made by the same general procedure.
Binding ratios, defined as moles of antibiotic bound per mole
of mononucleotide unit, were determined by the UV absor-
bance method (13).
Nuclease digestion of MC-M. lysodeikticus DNA complexes
(binding ratio, 0.15) was carried out by incubating 850 A20 units
of the complex in 170 ml of 0.14 M Tris/0.04 M MgCl2, pH
7.0, with a mixture of pancreatic DNase (10 units per A260 unit
of DNA), snake venom diesterase (0.14 units per A260 unit of
DNA), and alkaline phosphatase (0.14 units per A20 unit of DNA)
for 18 hr at 3000. EDTA was added to 0.025 M, and the mixture
was deproteinized by four extractions with CHCl3/isoamyl al-
cohol, 24:1 (vol/vol), followed by chromatography over a Seph-
adex G-25 column (5 X 55 cm) in 0.02 M NH4HCO3 buffer. The
void volume fraction contained the nuclease-resistant "core"
material. This was further purified from protein b.y chroma-
tography on DEAE-cellulose column (DE-52, Whatman; 1.5 X
17 cm). The protein was eluted first with 0.2 M NaCl/0.06 M
Tris, pH 7.4, and then the core was eluted with 0.6 M NaCl/
0.06 M Tris, pH 7.4. Its size range was estimated by compar-
ison of its elution volume with those of oligo(dA)12-18 and
oligo(dA)1o on a Sephadex G-100 column. Base analysis was car-
ried out by hydrolysis in 70% HC104 at 1000C, followed by neu-
tralization, centrifugation, and separation of the bases in the
supernatant by HPLC (Ultrasphere-octadecylsilica reverse-phase-
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type column, Beckman; solvent, 0.03 M potassium phosphate,
pH 6.3). Base ratios were calculated from comparison of the
peak areas.
CD spectra were recorded with a Cary 60 spectrophotome-
ter, as described (2). Molar ellipticity ([6]) was calculated per
nucleotide residue.
The extent of CD inversion of MC-poly(dG-dC).poly(dG-
dC) complexes is calculated from A[6] ([1]complex minus
[6]control) at 260 and 290 nm. A[0] of the saturation complex
(binding ratio, 0.22-0.25) is regarded as the value for 100% in-
verted CD. (The 0.22-0.25 ratio represents substitution of every
second base pair by MC, and it is not possible to introduce more
covalently bound MC.) The CD of this complex is given in Fig.
1A along with the Z form of poly(dG-dC)poly(dG-dC). Cal-
culated extents of inversion (% inversion) at 260 and 290 nm
agree closely.
31P NMR spectra were obtained with a Nicolet 360 wide-bore
spectrometer tuned to a frequency of 121.47 MHz. Spectra at
8 K were collected with a pulse width of 600 and a pulse rep-
etition rate of 1.5 sec. Two-level broad-band irradiation with 7-
and 3-W power was applied to the sample for full proton de-
coupling.
Competitive RIA with 3H-labeled Z-DNA was carried out as
described (14) under conditions of moderate and high ionic
strengths (60 mM sodium phosphate/30 mM EDTA, pH 8.0,
with 0.2 M or 4 M NaCl). Brominated poly(dG-dC)-poly(dG-dC)
was prepared as described (14) and showed the CD of Z-DNA
under both ionic conditions. The polymer was labeled by nick-
translation with 3[H]dGTP and 3[H]dCTP as described (14).
-,Contro poly(dG-dC)
lS0 08 FIG. 2. Ethanol-induced Bf Z transition of poly(dG-dC)-poly-
(dG-dC) (e) and its MC complexes
(a, *) as monitored by changes in
the UV spectra (A) and by CD
change at 290nm (B), both with in-
creasing percentage (wt/wt) of
ethanol in 1 mM sodium phos-
40 60 80 100 phate, pH 7.2/0.1 mM EDTA. The40 60 80 100 numbers near the curves indicate
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FIG. 3. 31p NMR at 121.47 MHz of sonicated control poly(dG-
dC)-poly(dG-dC) (A), MC-sonicated poly(dG-dC)poly(dG-dC) complex
(binding ratio, 0.17) (B), and MC-oligonucleotide core from M. lyso-
deikticusDNA (binding ratio, 0.23) (C). All spectra were taken in 0.012
M Tris, pH 7.4/1mM EDTA (20% 2H20) at 3.3-4.0mM nucleotide. For
these spectra, the number of scans accumulated are 10,240 (A), 15,360
(B), and 5,120 (C). Exponential line broadening of 5 Hz was applied to
all spectra. Chemical shifts are reported relative to the internal ref-
erence, trimethyl phosphate. (Inset) CD spectra of samplesA andB in
the same buffer. , Sample A at 0.1 mM nucleotide; ---, sample B
at the same concentration; and ---, sampleB at 1.2 mM nucleotide. (CD
was measured at 1-mm path length.)
Binding of 3H-labeled Z-DNA in 0.2 M NaCl with or without
various amounts of competitor was tested with a 1:1,500 di-
lution of a serum that reacted with Z-DNA but not with B-DNA
even at high serum concentration (14). For experiments in 4 M
NaCl, a 1:2,400 dilution of the serum was used.
RESULTS
Three distinct types of MC-polynucleotide complexes were se-
lected for study:
(i) MC-poly(dG-dC)poly(dG-dC) with various binding ratios.
The CD of these complexes is progressively inverted with in-
creasing binding ratio as shown previously (2). Fig. 1A shows
the CD spectra at the limiting binding ratio (0.22-0.25).
(ii) MC-M. lysodeikticus DNA with various binding ratios.
The CD of the complex (binding ratio, 0.15) is shown in Fig.
1B together with that of control DNA, indicating some inver-
sion.
(iii) Nuclease-resistant MC-oligonucleotide core from MC-M.
lysodeikticus DNA complexes. This was obtained, upon diges-
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FIG. 4. Competitive RIA of various MC-polynucleotide complexes
with 3H-labeled brominated poly(dG-dC)-poly(dG-dC) in 4 M NaCl/0.06
M sodium phosphate, pH 8.0/0.03 M EDTA. Inhibitors: A, poly(dG-
dC)poly(dG-dC); o, MC-poly(dG-dC)-poly(dG-dC) complex (binding ra-
tio, 0.04; curve 1); e, MC-poly(dG-dC)poly(dG-dC) complex (binding ra-
tio, 0.10; curve 2); A, MC-poly(dG-dC)poly(dG-dC) (binding ratio, 0.19;
curve 3); *, MC-M. lysodeikticus DNA complex (binding ratio, 0.07; curve
4); o, MC-oligonucleotide core from M. lysodeikticus DNA (binding ra-
tio, 0.23); and x, M. lysodeikticus DNA.
tion of the complex (binding ratio, 0.10-0.15) with a mixture
of nucleases, in 6-12% yield with the following properties:
binding ratio, 0.22-0.26; size range, 10-20 nucleotides; CD,
highly inverted (Fig. 1B); and base composition, 42.5% G, 43.1%
C, 7.5% T, and 6.9% A. The latter data clearly indicate that the
core had the composition of a double-stranded DNA with 86%
G+C content. In summary, it was a mixture of oligonucleotides
enriched in G+C (86%) relative to the parent DNA (72%) and
enriched in bound MC, containing the saturation amount of
drug (binding ratio, 0.22-0.26). Its CD had a greatly increased
negative minimum at 293 nm and a further shift of the positive
maximum to lower wavelength, compared to the undigested
complex (Fig. 1B), and 80% inversion was calculated when
compared to the complex in Fig. 1A. In view of these prop-
erties, it appeared possible that the core is a mixture of short
pieces of Z-DNA.
Ethanol-Induced B -- Z Transition of Unmodified and MC-
Modified poly(dG-dC)-poly(dG-dC). The transition was moni-
tored by two methods, first used by Pohl (10): change of A295/
A20 (Fig. 2A) and change of (ER - EL) at 290 nm with in-
creasing ethanol concentration (Fig. 2B). The complex with a
binding ratio of 0.01 required the same or slightly higher ethanol
concentration for transition midpoint than did unmodified
poly(dG-dC)Qpoly(dG-dC) (54% vs. 52%) (Fig. 2A), whereas the
complex with a binding ratio of 0.08 showed essentially no tran-
sition even though its CD (not shown) was only about 40% in-
verted relative to that of the saturation complex shown in Fig.
1A. The results in Fig. 2B (the descending part of the control
curve is the B -+ Z transition) confirm the lack of B -* Z tran-
sition of this complex. In summary, the transition is not facil-
itated but rather is inhibited with increasing binding ratio of
the MC-poly(dG-dC)poly(dG-dC) complex.
31P NMR. MC-sonicated poly(dG-dC)-poly(dG-dC) complex
(binding ratio, 0.17). Figs. 3 A and B show the spectra of the
sonicated poly(dG-dC)poly(dG-dC) control and MC bound to
poly(dG-dC)poly(dG-dC). Like the control, the spectrum of
the complex shows a single peak centered at 4.3 ppm upfield
from the internal trimethylphosphate standard. The CD for this
complex (Fig. 3 Inset) shows 68% inversion relative to that of
the saturated complex (Fig. 1A). Based on a binding ratio of
0.17 MC per nucleotide, we could expect a second peak at 2.8
0
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ppm, characteristic of Z-DNA (5, 15, 16), with a peak intensity
of 34% of the main band. Although this peak would easily be
detected above background, no such peak is apparent. There-
fore, the spectra do not support a conversion to Z-DNA. Some
broadening and a slight peak splitting (" 10 Hz) are evident,
however, with MC binding; the linewidths for sonicated poly(dG-
dC).poly(dG-dC) and MC-poly(dG-dC)poly(dG-dC) complex
are 49 Hz and 97 Hz, respectively.
MC-oligonucleotide core from M. lysodeikticus DNA (bind-
ing ratio, 0.26). The 31P NMR spectrum of this core complex(Fig. 3C) also showed a single resonance at 4.2 ppm with a line-
width of 61 Hz and some fine splitting. Again, although-the CD
of the substance (Fig. 1B) showed an inverted spectrum char-
acteristic of Z-DNA, there was no indication of a second peak
at 2.8 ppm in the 31P NMR spectrum.
Lack of concentration dependence of the CD. Because the
NMR experiments are conducted at much higher polynucleo-
tide concentration than that used for CD experiments (3.3 mM
vs. 0.1 mM in our case), we were concerned about the possi-
bility that the CD of the NMR samples might be different from
the CD of the dilute samples due to a concentration-dependent
conformational change (cf. ref. 17). No appreciable difference
was seen, however, between the CDs of the usual 0.1 mM and
a 1.2 mM sample of the MC-poly(dG-dC)poly(dG-dC) com-
plex, even though the latter corresponds to a 12-fold increase
in polynucleotide concentration (Fig. 3 Inset). The latter con-
centration is of the same order of magnitude as that of the NMR
samples (3.3 mM). Furthermore, integration of the 31P NMR
spectrum of MC-poly(dG-dC)poly(dG-dC) yielded values con-
sistent with the expected polynucleotide concentration, sug-
gesting that there was no aggregation or precipitation at high
concentration. These results indicate that the CD and NMR
spectra reflect the same conformation.
Competitive RIAs with 3H-Labeled Z-DNA. In 0.2 M NaCl/
0.06 M sodium phosphate, pH 8.0/0.03 M EDTA, none of the
following samples showed any competition for Z-DNA-specific
antibody with 3H-labeled brominated poly(dG-dC) poly(dG-dC)(14): control poly(dG-dC)poly(dG-dC), three different MC-
poly(dG-dC)-poly(dG-dC) complexes (binding ratio, 0.04, 0. 10,
and 0.19), control M. lysodeikticus DNA, MC-M. lysodeikticus
DNA complex (binding ratio, 0.07), and MC-oligonucleotide core
from M. lysodeikticus DNA (binding ratio, 0.23). _
In 4 M NaCl/0.06 M sodium phosphate, pH 8.0/0.03 M
EDTA, competition was observed by control poly(dG-dC).
poly(dG-dC) and each of its three complexes above (Fig. 4).
However, the more the polynucleotide was modified by MC,
the less it was able to compete with the Z-DNA of the assay;
the M. lysodeikticus DNA samples were all negative (Fig. 4).
RIAs with a Monoclonal Antibody H241. The monoclonal
antibody H241 (unpublished data) reacts with native or dena-
tured DNA and with poly(dG-dC)-poly(dG-dC). In the latter
case, the antibody prefers the B form and binds more strongly
to it than to Z-DNA or calf thymus DNA. MC-poly(dG-dC)-
poly(dG-dC) complexes and unsubstituted poly(dG-dC)-poly-(dG-dC) were tested as competitors of native calf thymus[3H]DNA for this antibody in 0.2 M NaCl/0. 06 M sodium phos-
phate, pH 8.0/0.03 M EDTA. The complexes with binding ra-
tios of 0.04 and 0.10 displayed competitions identical to that by
unsubstituted poly(dG-dC)-poly(dG-dC). The complex with the
highest binding ratio (0.19) still inhibited completely but re-
quired 5 times higher concentration.
DISCUSSION
The ethanol-induced cooperative B -- Z transition of poly(dG-dC)*poly(dG-dC) (10) has provided a useful method for probing
various covalent modifications of poly(dG-dC)poly(dG-dC)for
their ability to stabilize the Z-DNA structure. The method con-
sists simply of comparison of the ethanol concentration re-
quired for the transition of modified and unmodified poly(dG-dG)poly(dG-dC). A lower concentration in the former case in-
dicates that the modification promotes the Z structure. Thus,
poly(dG-dC)poly(dG-dC) modified by the carcinogen N-ace-
toxy-N-2-acetylaminofluorene at 3% of the bases required 45%
ethanol, compared to 50-55% ethanol for the control (18),
whereas 6.6% modification of the bases lowered the require-
ment to 25% ethanol concentration for the transition (19). Sim-
ilar trends were observed in the case of poly(dG-m5dC)-poly(dG-
m5dG) (20), poly(m7dG-dC)-poly(m7dG-dC) (21), and poly(dG-
dC)poly(dG-dC) modified by a platinum compound (17). In each
of these examples, the increased stability of Z-DNA was con-
firmed by other criteria as well. However, the mitomycin-in-
duced modification of poly(dG-dC)-poly(dG-dC) does not fa-
cilitate the transition (Fig. 2 A and B). Indeed, the results show
that it inhibits it. This indicates that some blocks exist to the
spread of the cooperative B -- Z change occurring at high ethanol
concentration.
The RIAs with 3H-labeled Z-DNA indicated very clearly that
under physiological conditions the Z-DNA-specific antibody did
not recognize even the most highly substituted MC-poly(dG-
dC)-poly(dG-dC) complex (binding ratio, 0.19), although the CD
of this complex is essentially fully inverted under similar con-
ditions (cf. Fig. 1A). This result in itself would not be sufficient
to rule out Z-DNA because it might be argued that the "bulky
substituent" MC interferes with antibody recognition. How-
ever, evidence against this argument comes from testing the
complexes with a monoclonal antibody, H241, which reacts with
native or denatured DNA and with poly(dG-dC)-poly(dG-dC).
In the latter case, the antibody prefers the B form and binds
more strongly to it than to Z-DNA or calf thymus DNA (un-
published data). The MC-poly(dG-dC)-poly(dG-dC) complexes
with binding ratio 0.04 and 0.10 each showed identical reac-
tivity toward this antibody with that of unsubstituted poly(dG-
dC)poly(dG-dC).
One can conclude from these results, that the bound MC,
at least up to a substitution level of 0.10 (20% of the guanines
substituted!) did not hinder access to the backbone of DNA,
nor did the complexes show any Z character. At the highest
substitution, it is possible that there was some hindrance but
not enough to account for the failure to inhibit the anti-Z-DNA.
It is also possible that the highest substitution. causes a con-
formationaltchange that is not Z but still makes it a less effective
inhibitor of H241 than samples 1 or 2.
Further, a strong indication that the results of the RIAs are
not a function of substituent hindrance is provided by the ethanol
transition studies. They show independently that increasing
binding ratio of MC results in progressive inhibition of the B
-- Z transition (Figs. 2 and 3). This confirms that the results
of the immunoassays in 4 M NaCl (Fig. 4) indicate the same
phenomenon-i.e., that increasing binding ratio of the MC-
poly(dG-dC)-poly(dG-dC) complex progressively inhibits the
transition iu the Z structure under the high salt conditions. This
interpretation provides a striking consistency between the re-
sults of the two different types of experimental approaches(physicochemical and immunological.)
From this it may be concluded that a structural barrier is
present in MC-modified poly(dG-dC)-poly(dG-dC), preventing
the formation of Z-DNA under the usual conditions. [Recent-
ly a similar inhibition of the B-UZ transition was observed in
aflatoxin B1-poly(dG-dC).poly(dG-dC) complexes (22). ] This is
noticeable even at the low levels of 1, 4, and 8% base substi-
tutions. This may be a general effect of crosslinking agents and
could have biological significance.
The M. lysodeikticus DNA samples modified by MC also
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showed no Z structure when tested with the Z-DNA-specific
antibody. This was true for the nuclease-resistant MC-oligonu-
cleotide core from the DNA as well, even though this sub-
stance, which has 80% inverted CD and 86% G+C content, ap-
peared to be a most promising candidate for Z-DNA originally.
31P NMR experiments provide a unique probe for the dinu-
cleotide repeat, characteristic of Z-DNA (5, 15, 16). The MC-
sonicated poly(dG-dC) poly(dG-dC) sample had a calculated 86%
inversion of CD; if this were due to Z-DNA, one would expect
two phosphorus resonances at =2.8 and -4.3 ppm upfield from
the internal standard trimethylphosphate in an intensity ratio of
34:66. The appearance of the former resonance would indicate
the inequivalence of neighboring phosphates in Z-DNA (5, 15,
16). Only one peak is evident, however, at the position of that of
the control (4.30 ppm). Similarly, the core (calculated CD inver-
sion, 80%o), if Z-DNA, may be expected to display the two peaks
in an approximate intensity ratio of 40:60; but again, only the usual
DNA peak at 4.20 ppm is present. These results support the lack
of Z-DNA upon modification by MC. Because the 31P NMR shifts
for Z-DNA have been reported mostly for unmodified poly(dG-
dC)poly(dG-dC), extension to covalently modified polynucleo-
tides should be exercised with some caution until more cases of
such correlations become known. Thus far a positive correlation
has been seen in two cases (see refs. 17 and 23).
What is then the origin of the inversion of the CD in these
drug-polynucleotide complexes? There are two a priori possi-
bilities. (i) It is due to true conformational changes of the poly-
nucleotide, but no Z-DNA is involved. (ii) The CD change is the
result of electronic interaction between base chromophores and
covalently bound mitomycin, giving rise to additional Cotton ef-
fects (induced CD) (24), which are superimposed on the usual CD
of B-DNA. Both alternatives have been discussed in our earlier
paper (2). The first one gained new interest in view of the recent
discovery of several types of left-handed DNA structures dis-
tinct from Z-DNA in solution, all characterized by inverted type
CD spectra and alternating dG-dC sequences (25). A test for the
change in handedness, namely relaxation of appropriate super-
coiled topoisomers (25) cannot be applied unambiguously to MC-
modified plasmids because relaxation of the latter has been re-
ported to take place as a result of some single-strand cleavage due
to superoxide formation during the usual procedure of reduc-
tive activation of MC (26). That conformational changes do exist
in DNA modified by MC was reported recently from one of our
laboratories (27). Hydrodynamic and electron microscopic evi-
dence indicated greatly increased flexibility of limited regions
in MC-calf thymus DNA complexes. Further indications for a
deviation from the B-DNA conformation was provided by tran-
sient electric dichroism studies (28). Although the hypothesis of
Z-DNA is no longer feasible to explain these effects, left-handed
DNA remains a distinct possibility. A test that discriminates be-
tween right-handed and left-handed DNA in solution is under
development (29) and may be applicable to this problem.
Induced CD, a second potential cause of the CD inversion of
MC-polynucleotide complexes, receives some supportive evi-
dence from recent chemical results: a mitomycin-deoxyguano-
sine adduct was recently isolated that had an intense CD spec-
trum with negative and positive Cotton effects resembling
somewhat the CD of Z-DNA (30). Thus, the inverted CD of MC-
poly(dG-dC)poly(dG-dC) could result from the sum of the CD
of B-DNA and of the extrinsic CD of deoxyguanosine-MC ad-
ducts. It should be noted that MC does not intercalate between
base pairs (27) and, therefore, the electronic interaction, if any,
does not arise from intercalative stacking. Somewhat similar CDs
of adducts between 7,12-dimethylbenzanthracene and guano-
sine (31) as well as between N-2-acetylaminofluorene and some
mono- and dinucleoside-phosphates (32) have been reported in
the literature.
The present finding that Z-DNA-like inverted CD can result
from factors other than the presence of Z-DNA underscores the
need for caution in interpreting such CD changes. The power
of the particular combination of the three tests for Z-DNA used
here is clearly demonstrated and it should be equally useful and
conclusive for negative and positive cases.
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